Article

Overexpression of Truncated I B Induces TNF- -Dependent Apoptosis in Human Vascular Smooth Muscle Cells

Department of Internal Medicine, Keio University, Edo, Tokyo, Japan
Arteriosclerosis Thrombosis and Vascular Biology (Impact Factor: 6). 11/2000; 20(10):2198-204. DOI: 10.1161/01.ATV.20.10.2198
Source: PubMed

ABSTRACT

Dysregulation of apoptosis is one of the likely underlying mechanisms of neointimal thickening, a disorder in which proinflammatory cytokines may influence the function of vascular smooth muscle cells (VSMCs) and contribute to atherogenesis. One of these cytokines, tumor necrosis factor-alpha (TNF-alpha), induces 2 possibly conflicting pathways, 1 leading to the activation of nuclear factor-kappaB (NF-kappaB) and the other leading to caspase-mediated apoptosis. We investigated whether specific inhibition of NF-kappaB affects TNF-alpha-dependent apoptosis in human VSMCs. To inhibit NF-kappaB activation specifically, we constructed a recombinant adenovirus vector expressing a truncated form of the inhibitor protein IkappaBalpha (AdexIkappaBDeltaN) that lacks the phosphorylation sites essential for activation of NF-kappaB. The IkappaBDeltaN was overexpressed by adenoviral infection and was resistant to stimulus-dependent degradation. Electromobility gel shift and luciferase assays demonstrated that overexpression of IkappaBDeltaN inhibited NF-kappaB activation induced by TNF-alpha or interleukin-1beta (IL-1beta). In cells overexpressing IkappaBDeltaN, TNF-alpha dramatically induced apoptosis, whereas IL-1beta had no effect. The induction was suppressed by treatment with a selective inhibitor of the caspase-3 family, Z-DEVD-fmk, and the overexpression of IkappaBDeltaN induced TNF-alpha-mediated caspase-3 and caspase-2 activity. These results indicate that overexpression of IkappaBDeltaN induces TNF-alpha-dependent apoptosis by efficient and specific suppression of NF-kappaB and upregulation of caspase-3 and caspase-2 activity in human VSMCs. Our findings suggest that adenovirus-mediated IkappaBDeltaN gene transfer may be useful in the treatment of disorders associated with inflammatory conditions, such as the response to vascular injury and atherosclerosis.

Download full-text

Full-text

Available from: Go Wakabayashi
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hintergrund: Proinflammatorische Cytokine wie TNF-alpha und IL-6 sowie prokoagulatorische Mediatoren wie TF, die durch LPS-Stimulierung via Monozyten freigesetzt werden, sind mit koronarer Atherosklerose und akuten Koronarsyndromen assoziiert. LPS bindet im Rahmen dieser Aktivierungsreaktion über den Rezeptor CD14 an die Zellen. Im Promotor des CD14-Gens wurde ein bialleler (-159 C/T) Polymorphismus beschrieben. Homozygotie für das T-Allel konnte als unabhängiger Risikofaktor für Myokardinfarkte identifiziert werden. Fragestellung: Wir untersuchten In-Vitro, ob sich der (T-159C)-Polymorphismus im Promotor des CD14-Gens allelabhängig im Sinne einer stärkeren bzw. schwächeren proinflammatorischen und prokoagulatorischen Reaktion von Monozyten auf eine LPS-Stimulierung auswirkt. Methodik: Die TF-Aktivität wurde mit einem Ein-Schritt-Gerinnungstest (PCA) bestimmt. Quantitativ wurde die TF-Konzentration mit einem chromogenen TF-Assay ermittelt. In den Zellüberständen erfolgte eine Konzen-trationsmessung von TNF-alpha und IL-6 mittels konventioneller Enzymimmunoassays. Die Messungen wurden bei kultivierten, genotypisierten Monozyten (120 gesunde Probanden ) in Ruhe und nach LPS-Simulation durchgeführt. Die Messergebnisse der drei Allelgruppen wurden statistisch mit dem ANOVA-Test und anschließender Signifikanzprüfung nach Scheffe ausgewertet. Ergebnisse: Die Genotypverteilung wurde mit CC 31,6%, CT 46,7% und TT 21,7% berechnet. Es konnten bei der Bestimmung von TNF-alpha, IL-6 und TF (PCA/chromogener TF-Assay) mit und ohne LPS-Stimulation keine signifikanten Unterschiede zwischen den drei Allelgruppen gezeigt werden (p = ns). Schlußfolgerung: Es konnte kein Zusammenhang zwischen dem biallelen (-159 C/T) CD14-Polymorphismus und stärkerer bzw. schwächerer Mediatorsynthese nach LPS-Exposition von Monozyten nachgewiesen werden. Damit konnte keine mögliche Erklärung für die positive Assoziation TT-Homozygoter mit Myokardinfarkten in früheren Studien gefunden werden. Vielmehr scheint die vorliegende Studie eine prospektive Untersuchung zu bestätigen, in der kein Zusammenhang zwischen dem CD14-Promotorpolymorphismus und Myokardinfarkten gefunden wurde. Weitere experimentelle Studien unter Berücksichtigung der Komplexität des Themas infektassoziierte KHK müssen folgen, um den Stellenwert des CD14-Promotorpolymorphismus zu klären.
    Preview · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intimal proliferation of smooth muscle cells (SMCs) is a key event in the vascular response to injury, including the early stages of atherosclerosis and restenosis after angioplasty. Tumor necrosis factor-alpha (TNF-alpha) has been reported to stimulate growth of cultured human SMCs, but activation of TNF receptors is also known to induce cell death by apoptosis. We report here that SMCs isolated from the neointima of injured rat aortas are characterized by increased expression of TNF-alpha in response to interleukin-1beta and gamma-interferon compared with medial SMCs. Basal and serum-stimulated DNA synthesis was higher in intimal than in medial SMCs. In contrast to previous findings on human SMCs, exposure to interleukin-1beta/gamma-interferon or TNF-alpha did not affect the growth of rat medial SMCs, inhibited DNA synthesis, and decreased cell numbers in cultures of intimal SMCs. Incubation of intimal SMCs with these cytokines also resulted in induction of terminal dUTP nick end-labeling positivity and caspase-3 expression, suggesting cell death by apoptosis, whereas medial cells were markedly less sensitive in this respect. Cytokine-induced apoptosis in intimal cells was effectively inhibited by treatment with antibodies against TNF receptors. These findings suggest that endogenous activation of TNF receptors may represent a way to limit accumulation of SMCs in injured arteries. This mechanism may also be important in SMC death in advanced atherosclerotic plaques.
    Full-text · Article · Jan 2002 · Arteriosclerosis Thrombosis and Vascular Biology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inflammatory reaction and intimal proliferation of smooth muscle cells are characteristics of vascular stenotic lesions. Nuclear factor kappaB (NF-kappaB) is involved in regulation of inflammation and cell survival in a variety of cell types. We tested a hypothesis that selective inhibition of NF-kappaB by expression of a mutated, nondegradable inhibitor of NF-kappaB, IkappaB-alphaM, would inhibit proinflammatory cytokine expression and proliferation in human vascular smooth muscle cell. Smooth muscle cells were cultured from internal mammary artery and infected with recombinant adenovirus vectors. Adenoviral expression of IkappaB-alphaM inhibited diverse signal-triggered cellular IkappaB-alpha degradation, subsequent NF-kappaB activation, and transactivation of proinflammatory cytokine genes. Expression of IkappaB-alphaM in low-density VSMC led to a 60% reduction in serum-stimulated cell growth and a 10% increment in apoptotic incidence but was without effect in high-density cultures. Coexpression of NF-kappaB p65 attenuated apoptosis in low-density cells induced by IkappaB-alphaM. Therefore, the susceptibility to apoptosis induction in the low-density cells correlated with lower constitutive NF-kappaB activity. The induction of apoptosis by IkappaB-alphaM and the rescue by NF-kappaB p65 might be explained by mutual control of NF-kappaB p65 and IkappaB-alphaM access to the nucleus. Our results suggest that expression of nondegradable IkappaB-alpha might have therapeutic potential in both vascular inflammatory reaction and smooth muscle cell proliferation.
    No preview · Article · Mar 2002 · Journal of Surgical Research
Show more